140 related articles for article (PubMed ID: 10371338)
1. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis.
Handa K; Yamakawa M; Takeda H; Kimura S; Takahashi T
Int J Cancer; 1999 Jun; 84(3):225-33. PubMed ID: 10371338
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.
Bahnassy AA; Zekri AR; El-Houssini S; El-Shehaby AM; Mahmoud MR; Abdallah S; El-Serafi M
BMC Gastroenterol; 2004 Sep; 4():22. PubMed ID: 15385053
[TBL] [Abstract][Full Text] [Related]
3. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
6. Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma.
Wong SC; Chan AT; Lo ES; Lo YM
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):248-51. PubMed ID: 16082250
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index.
Basolo F; Caligo MA; Pinchera A; Fedeli F; Baldanzi A; Miccoli P; Iacconi P; Fontanini G; Pacini F
Thyroid; 2000 Sep; 10(9):741-6. PubMed ID: 11041450
[TBL] [Abstract][Full Text] [Related]
11. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.
Kushner J; Bradley G; Young B; Jordan RC
J Oral Pathol Med; 1999 Feb; 28(2):77-81. PubMed ID: 9950254
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
15. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Nagao T; Ishida Y; Kondo Y
Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
[TBL] [Abstract][Full Text] [Related]
16. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.
Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T
J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
19. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 mRNA in colorectal carcinomas and relationship to clinicopathological features: an in situ hybridization analysis.
Kristt D; Turner I; Koren R; Ramadan E; Gal R
Pathol Oncol Res; 2000; 6(1):65-70. PubMed ID: 10749591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]